Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

FDA advisory panel recommends approval of the Heart Laser System

April 28, 1998

Glaxo Wellcome terminates clinical trial for septic shock agent

April 27, 1998

Dofetilide exerts atrial positive inotropic effect in AF patients following cardioversion

April 27, 1998

Oral levosimendan effectively substitutes for i.v. inotropic therapy

April 27, 1998

Crystaal in-licenses Neurex's Corlopam

April 27, 1998

Ono presents new iNOS inhibitors

April 24, 1998

CP-060S: a cardioprotective agent with a novel mechanism of action

April 24, 1998

Study finds diuretics with beta-blockers to be most efficient in lowering blood pressure

April 24, 1998

CytRx announces manufacturing agreement with Abbott

April 23, 1998

Searle introduces new formulation of verapamil hydrochloride in Canada

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...